PyIgClassify2: Canonical Clusters of Antibody CDR Loop Conformations

PyIgClassify2: Classification of Antibody CDR Conformations

CDRs for query 5VL2

#CDRs = 4; #Clusters = 4.
Chain	Gene	PDB Species	Frame Germline	Frame %	CDR Germline	CDR %	CDR	Length	Cluster	Distance(°)	Sequence	Ramachandran
A	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	61.5	H1	13	H1-13-*	-1	AASGRTHTPYAMG	BBBEBBBAABBBB
A	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	20.0	H2	10	H2-10-*	-1	GIGGVAATTT	BBBEAALBBB
A	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	50.0	H3	17	H3-17-*	-1	ATRASMAVStspRVYPI
A	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	75.0	H4	8	H4-8-1	7	RDDAKATV	BBAAALBB
B	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	61.5	H1	13	H1-13-*	-1	AASGRTHTPYAMG	BBBEBBBAABBBB
B	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	20.0	H2	10	H2-10-*	-1	GIGGVAATTT	BBBEABBBBB
B	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	50.0	H3	17	H3-17-*	-1	ATRASMAVStspRVYPI
B	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	75.0	H4	8	H4-8-1	7	RDDAKATV	BBAAALBB
C	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	61.5	H1	13	H1-13-*	-1	AASGRTHTPYAMG	BBBEBBBAABBBB
C	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	20.0	H2	10	H2-10-*	-1	GIGGVAATTT	BBBEAALBBB
C	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	50.0	H3	17	H3-17-*	-1	ATRASMAVStspRVYPI
C	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	75.0	H4	8	H4-8-1	8	RDDAKATV	BBAAALBB
D	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	61.5	H1	13	H1-13-*	-1	AASGRTHTPYAMG	BBBEBBBAABBBB
D	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	20.0	H2	10	H2-10-*	-1	GIGGVAATTT	BBBEAALBBB
D	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	50.0	H3	17	H3-17-*	-1	ATRASMAVStspRVYPI
D	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	75.0	H4	8	H4-8-1	9	RDDAKATV	BBAAALBB
E	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	61.5	H1	13	H1-13-*	-1	AASGRTHTPYAMG	BBBEBBBAABBBB
E	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	20.0	H2	10	H2-10-*	-1	GIGGVAATTT	BBBEAALBBB
E	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	50.0	H3	17	H3-17-*	-1	ATRASMAVStspRVYPI
E	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	75.0	H4	8	H4-8-1	9	RDDAKATV	BBAAALBB
F	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	61.5	H1	13	H1-13-*	-1	AASGRTHTPYAMG	BBBEBBBAABBBB
F	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	20.0	H2	10	H2-10-*	-1	GIGGVAATTT	BBBEABBBBB
F	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	50.0	H3	17	H3-17-*	-1	ATRASMAVStspRVYPI
F	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	75.0	H4	8	H4-8-1	10	RDDAKATV	BBAAALBB
G	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	61.5	H1	13	H1-13-*	-1	AASGRTHTPYAMG	BBBEBBBAABBBB
G	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	20.0	H2	10	H2-10-*	-1	GIGGVAATTT	BBBEAALBBB
G	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	50.0	H3	17	H3-17-*	-1	ATRASMAVStspRVYPI
G	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	75.0	H4	8	H4-8-1	7	RDDAKATV	BBAAALBB
H	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	61.5	H1	13	H1-13-*	-1	AASGRTHTPYAMG	BBBEBBBAABBBB
H	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	20.0	H2	10	H2-10-*	-1	GIGGVAATTT	BBBEAALBBB
H	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	50.0	H3	17	H3-17-*	-1	ATRASMAVStspRVYPI
H	heavy	Lama.glama	La_IGHV1S1*01_VHH	89.0	La_IGHV1S1*01_VHH	75.0	H4	8	H4-8-1	6	RDDAKATV	BBAAALBB

Site developed by the Antibody Team at the lab of Roland Dunbrack. Last updated on Oct. 13, 2022